(Reuters) – Merck said on Thursday its treatment for a type of uterus cancer did not meet the main goal of disease-free survival in a late-stage trial.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shounak Dasgupta)
Merck treatment for a type of uterus cancer fails trial
May 9, 2024 | 7:05 AM
Comments